Asia Oceania Federation of Obstetrics and Gynecology, SLCOG HOUSE, Colombo, Sri Lanka.
Department of Obstetrics and Gynecology, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.
J Obstet Gynaecol Res. 2024 Oct;50 Suppl 1:42-48. doi: 10.1111/jog.16032.
Cervical cancer poses a significant health burden, particularly in low- and middle-income countries, where access to screening and treatment remains limited. Asia Oceania Federation of Obstetrics and Gynecology (AOFOG)'s response, guided by the World Health Organization's global strategy, emphasizes three key targets: achieving high HPV vaccination coverage among girls, ensuring widespread screening with high-performance tests, and guaranteeing timely treatment for precancerous and cancerous lesions. AOFOG supports member countries through initiatives such as educational campaigns, guidelines development, and collaboration with local and international partners. Variations in screening methods across AOFOG member countries reflect diverse socioeconomic contexts and healthcare infrastructures, ranging from HPV testing in countries like Australia and Malaysia to cytology and visual inspection methods in others. Innovations such as HPV self-testing and AI-enhanced screening are emerging to improve accessibility and accuracy, addressing barriers like stigma and resource scarcity. Despite challenges, AOFOG remains committed to reducing cervical cancer incidence and mortality through coordinated regional efforts, aiming for equitable access to preventive measures and treatment across the diverse landscape of the Asia-Pacific region.
宫颈癌对健康造成重大负担，尤其在中低收入国家，这些国家的筛查和治疗资源仍然有限。亚洲大洋洲妇产科联盟（AOFOG）以世界卫生组织的全球战略为指导，针对三个关键目标做出回应：在女孩中实现高 HPV 疫苗接种覆盖率，确保广泛使用高性能检测方法进行筛查，并为癌前病变和癌症病变提供及时治疗。AOFOG 通过教育活动、指南制定以及与本地和国际合作伙伴的合作，为成员国提供支持。AOFOG 成员国的筛查方法存在差异，反映了不同的社会经济背景和医疗保健基础设施，从澳大利亚和马来西亚等国家的 HPV 检测，到其他国家的细胞学和目视检查方法。HPV 自我检测和人工智能增强筛查等创新方法的出现，旨在提高可及性和准确性，解决污名化和资源匮乏等障碍。尽管面临挑战，AOFOG 仍致力于通过协调区域努力，减少宫颈癌的发病率和死亡率，旨在在亚太地区多样化的背景下，实现预防措施和治疗的公平获取。
